What is the dosage and use of Delamanid?

Delamanid(Delamanid) is an anti-tuberculosis drug derived from nitrodihydroimidazole compounds that inhibit the synthesis of mycolic acid in bacterial cell walls. It is used as an antibiotic to treat multidrug-resistant tuberculosis. The recommended dose of delamanid is 100 mg twice a day for 24 weeks, after meals.

Delamani is a relatively new experimental drug that is effective against both susceptible and resistant strains of Mycobacterium tuberculosis. It is already approved for the treatment of tuberculosis in EU countries (trade name: Deltyba) and Japan as part of combination therapy for multidrug-resistant tuberculosis. During clinical trials, delamani underwent small group studies designed to determine safety and effectiveness. Common adverse reactions to delamanidwere observed in healthy subjects during clinical studies. These side effects include headache, nausea, and dizziness. In a recent clinical trial, 481 MDR-TB patients on a background MDR-TB regimen were randomized to receive delamanid 100 mg twice daily, delamanid 200 mg twice daily, or placebo. Delamanid demonstrated asymptomatic prolongation of the QT interval in both treatment groups (13.1% and 9.9%) compared with placebo (3.8%). If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.

xa0

xa0